Byung-Noe Bae
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Byung-Noe Bae has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
Geumhee Gwak
Department of General Surgery, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea
10 shared publicationsHyunjin Cho
Department of General Surgery, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea
9 shared publicationsInseok Park
Department of General Surgery, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea
8 shared publicationsKeun Ho Yang
Department of Surgery, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea
7 shared publications- Sehwan Han
Department of Surgery, Ajou University School of Medicine, Suwon, Korea
6 shared publications Keunho Yang
Department of General Surgery, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea
5 shared publications
Latest Publications
- Open Access
- 31 October 2021
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 37 (5) , 298-305
Effect of Adjuvant Chemotherapy on Elderly Stage II High-Risk Colorectal Cancer Patients
Purpose: Adjuvant chemotherapy (AC) is recommended for patients with stage II colorectal cancer with adverse features. However, the effect of adjuvant treatment in elderly patients with high-risk stage II colorectal cancer remains controversial. This study aimed to investigate the oncologic outcomes in elderly high-risk stage II colorectal cancer patients who underwent curative resection with or without AC.Methods: Patients aged over 70 years having stage II colorectal adenocarcinoma with at least 1 adverse feature who underwent radical surgery between 2008 and 2017 at a single center were included. We compared recurrence-free survival (RFS) and overall survival (OS) between patients who received more than 80% of the planned AC cycle (the AC+ group) and those who did not receive it (the AC− group).Results: The AC+ and AC– group contained 46 patients and 50 patients, respectively. The log-rank test revealed no significant intergroup differences in RFS (P = 0.083) and OS (P = 0.122). In the subgroup of 27 patients with more than 2 adverse features, the AC+ group (n = 16) showed better RFS (P = 0.006) and OS (P = 0.025) than the AC− group. In this subgroup, AC was the only significant factor affecting RFS in the multivariate analysis (P = 0.023). AC was significantly associated with OS (P = 0.033) in the univariate analysis, but not in the multivariate analysis (P = 0.332).Conclusion: Among elderly patients with stage II high-risk colorectal cancer, the AC+ group did not show better RFS or OS than the AC− group. However, selected patients with more than 2 adverse features might benefit from AC.
- 31 October 2021
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 37 (5) , 298-305
Open AccessEffect of Adjuvant Chemotherapy on Elderly Stage II High-Risk Colorectal Cancer Patients
Purpose: Adjuvant chemotherapy (AC) is recommended for patients with stage II colorectal cancer with adverse features. However, the effect of adjuvant treatment in elderly patients with high-risk stage II colorectal cancer remains controversial. This study aimed to investigate the oncologic outcomes in elderly high-risk stage II colorectal cancer patients who underwent curative resection with or without AC.Methods: Patients aged over 70 years having stage II colorectal adenocarcinoma with at least 1 adverse feature who underwent radical surgery between 2008 and 2017 at a single center were included. We compared recurrence-free survival (RFS) and overall survival (OS) between patients who received more than 80% of the planned AC cycle (the AC+ group) and those who did not receive it (the AC− group).Results: The AC+ and AC– group contained 46 patients and 50 patients, respectively. The log-rank test revealed no significant intergroup differences in RFS (P = 0.083) and OS (P = 0.122). In the subgroup of 27 patients with more than 2 adverse features, the AC+ group (n = 16) showed better RFS (P = 0.006) and OS (P = 0.025) than the AC− group. In this subgroup, AC was the only significant factor affecting RFS in the multivariate analysis (P = 0.023). AC was significantly associated with OS (P = 0.033) in the univariate analysis, but not in the multivariate analysis (P = 0.332).Conclusion: Among elderly patients with stage II high-risk colorectal cancer, the AC+ group did not show better RFS or OS than the AC− group. However, selected patients with more than 2 adverse features might benefit from AC.
- Open Access
- 31 August 2021
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 37 (4) , 259-265
Prognostic Factors Affecting Disease-Free Survival and Overall Survival in T4 Colon Cancer
Purpose: It is known that as the T stage of a carcinoma progresses, the prognosis becomes poorer. However, there are few studies about factors that affect the prognosis of T4 advanced colon cancer. This study aimed to identify the prognostic factors associated with disease-free survival (DFS) and overall survival (OS) in T4 colon cancer.Methods: Patients diagnosed with stage T4 on histopathology after undergoing curative surgery for colon cancer between March 2009 and March 2018 were retrospectively analyzed for factors related to postoperative survival. Primary outcomes were DFS and OS.Results: Eighty-two patients were included in the study. DFS and OS of the pathologic (p) T4b group were not inferior to that of the pT4a group. Multivariate analysis showed that differentiation (hazard ratio [HR], 4.994; P = 0.005), and laparoscopic surgery (HR, 0.323; P = 0.008) were significant prognostic factors for DFS, while differentiation (HR, 7.904; P ≤ 0.001) and chemotherapy (HR, 0.344; P = 0.038) were significant prognostic factors for OS.Conclusion: Tumor differentiation, laparoscopic surgery, and adjuvant chemotherapy were found to be significant prognostic factors in patients with T4 colon cancer. Adjuvant chemotherapy and curative resections by laparoscopy might improve the prognosis in these patients.
- 31 August 2021
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 37 (4) , 259-265
Open AccessPrognostic Factors Affecting Disease-Free Survival and Overall Survival in T4 Colon Cancer
Purpose: It is known that as the T stage of a carcinoma progresses, the prognosis becomes poorer. However, there are few studies about factors that affect the prognosis of T4 advanced colon cancer. This study aimed to identify the prognostic factors associated with disease-free survival (DFS) and overall survival (OS) in T4 colon cancer.Methods: Patients diagnosed with stage T4 on histopathology after undergoing curative surgery for colon cancer between March 2009 and March 2018 were retrospectively analyzed for factors related to postoperative survival. Primary outcomes were DFS and OS.Results: Eighty-two patients were included in the study. DFS and OS of the pathologic (p) T4b group were not inferior to that of the pT4a group. Multivariate analysis showed that differentiation (hazard ratio [HR], 4.994; P = 0.005), and laparoscopic surgery (HR, 0.323; P = 0.008) were significant prognostic factors for DFS, while differentiation (HR, 7.904; P ≤ 0.001) and chemotherapy (HR, 0.344; P = 0.038) were significant prognostic factors for OS.Conclusion: Tumor differentiation, laparoscopic surgery, and adjuvant chemotherapy were found to be significant prognostic factors in patients with T4 colon cancer. Adjuvant chemotherapy and curative resections by laparoscopy might improve the prognosis in these patients.
- Open Access
- 31 July 2021
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 37 (Suppl 1) , S28-S33
Transmural Mesh Migration From the Abdominal Wall to the Rectum After Hernia Repair Using a Prolene Mesh: A Case Report
Mesh erosion or migration is a rare and late complication after hernia repair. Its incidence is increasing as the utilization of prosthetic mesh gains popularity for abdominal hernia repair. However, mesh migration is exceedingly rare and its clinical presentation is atypical and diverse. Therefore, the management of mesh migration should be individualized to each patient. This research reports the case of a 94-year-old man with transmural migration of Prolene mesh (Ethicon) from the abdominal wall to the rectum 14 years after incisional hernia repair. He presented with only chronic abdominal pain and constipation. Migration of the mesh and a fistula between the right abdominal wall and transverse colon was observed on computed tomography. The mesh was evacuated manually from the anus without any sequelae. These findings made this case atypical, since complete transluminal migration of mesh is exceedingly rare and mesh erosion or migration requires surgical treatment in many cases.
- 31 July 2021
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 37 (Suppl 1) , S28-S33
Open AccessTransmural Mesh Migration From the Abdominal Wall to the Rectum After Hernia Repair Using a Prolene Mesh: A Case Report
Mesh erosion or migration is a rare and late complication after hernia repair. Its incidence is increasing as the utilization of prosthetic mesh gains popularity for abdominal hernia repair. However, mesh migration is exceedingly rare and its clinical presentation is atypical and diverse. Therefore, the management of mesh migration should be individualized to each patient. This research reports the case of a 94-year-old man with transmural migration of Prolene mesh (Ethicon) from the abdominal wall to the rectum 14 years after incisional hernia repair. He presented with only chronic abdominal pain and constipation. Migration of the mesh and a fistula between the right abdominal wall and transverse colon was observed on computed tomography. The mesh was evacuated manually from the anus without any sequelae. These findings made this case atypical, since complete transluminal migration of mesh is exceedingly rare and mesh erosion or migration requires surgical treatment in many cases.
- Open Access
- 8 July 2020
- Published by XMLink in Journal of the Korean Society of Radiology
- Vol. 81 (4) , 1013-1018
Ascariasis Presenting as Hematoma in the Sigmoid Mesocolon: A Case Report
김지은, et al. J Korean Soc Radiol. 2020 Jul;81(4):1013-1018. https://doi.org/10.3348/jksr.2020.81.4.1013
- 8 July 2020
- Published by XMLink in Journal of the Korean Society of Radiology
- Vol. 81 (4) , 1013-1018
Open AccessAscariasis Presenting as Hematoma in the Sigmoid Mesocolon: A Case Report
김지은, et al. J Korean Soc Radiol. 2020 Jul;81(4):1013-1018. https://doi.org/10.3348/jksr.2020.81.4.1013
- Open Access
- 30 June 2020
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 36 (3) , 178-185
Prognostic Factors and Management for Left Colonic Perforation: Can Hartmann’s Procedure Be Preventable?
Purpose: To identify factors significantly associated with the mortality of patients with left colonic perforation, and to compare the outcome of Hartmann’s procedure (HP) and primary repair (PR) or primary anastomosis (PA) in patients with left colonic perforation without factors associated with mortality.Methods: This retrospective study included patients who underwent surgery for left colonic perforation from January 2009 to February 2018. Preoperative factors related to postoperative mortality, including vital signs, laboratory findings, and intraoperative findings, were analyzed by type of operation. The chi-square, Fisher exact, and Mann-Whitney U-tests were used to analyze the data.Results: Ninety-one patients were included (36 men, 55 women), and 15 (16.5%) died postoperatively. Prognostic factors were age, leukopenia, thrombocytopenia, bleeding tendency, acute kidney injury, hemodynamic instability, and the existence of feculent ascites. Leukopenia and longer operative time were independent risk factors for mortality. Seventy-nine patients did not have leukopenia and 30 of these patients who underwent PR without diversion were excluded from the subanalysis. HP was performed in 30 patients, and PR with diversion and PA with or without diversion were performed in 19. Compared to the other operative methods, HP had no advantage in reducing hospital mortality (P=0.458) and morbidity.Conclusion: Leukopenia could be an objective prognostic factor for left colonic perforation. Although HP is the gold standard for septic left colonic perforation, it did not improve the hospital mortality of the patients without leukopenia. For such patients, PR or PA may be suggested as an alternative option for left colonic perforation.
- 30 June 2020
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 36 (3) , 178-185
Open AccessPrognostic Factors and Management for Left Colonic Perforation: Can Hartmann’s Procedure Be Preventable?
Purpose: To identify factors significantly associated with the mortality of patients with left colonic perforation, and to compare the outcome of Hartmann’s procedure (HP) and primary repair (PR) or primary anastomosis (PA) in patients with left colonic perforation without factors associated with mortality.Methods: This retrospective study included patients who underwent surgery for left colonic perforation from January 2009 to February 2018. Preoperative factors related to postoperative mortality, including vital signs, laboratory findings, and intraoperative findings, were analyzed by type of operation. The chi-square, Fisher exact, and Mann-Whitney U-tests were used to analyze the data.Results: Ninety-one patients were included (36 men, 55 women), and 15 (16.5%) died postoperatively. Prognostic factors were age, leukopenia, thrombocytopenia, bleeding tendency, acute kidney injury, hemodynamic instability, and the existence of feculent ascites. Leukopenia and longer operative time were independent risk factors for mortality. Seventy-nine patients did not have leukopenia and 30 of these patients who underwent PR without diversion were excluded from the subanalysis. HP was performed in 30 patients, and PR with diversion and PA with or without diversion were performed in 19. Compared to the other operative methods, HP had no advantage in reducing hospital mortality (P=0.458) and morbidity.Conclusion: Leukopenia could be an objective prognostic factor for left colonic perforation. Although HP is the gold standard for septic left colonic perforation, it did not improve the hospital mortality of the patients without leukopenia. For such patients, PR or PA may be suggested as an alternative option for left colonic perforation.
- Open Access
- 15 March 2020
- Published by The Korean Society of Endo-Laparoscopic & Robotic Surgery in Journal of Minimally Invasive Surgery
- Vol. 23 (1) , 43-48
Unmodifiable Clinicopathological Risk Factors of Shoulder Tip or Subcostal Pain after Laparoscopic Appendectomy
Bomi Kim, M.D., Jungbin Kim, M.D., Inseok Park, M.D., Hyunjin Cho, M.D., Geumhee Gwak, Ph.D., Keun Ho Yang, Ph.D., Byung-Noe Bae, Ph.D., Kihwan Kim, Ph.D.. Journal of Minimally Invasive Surgery 2020;23:43-8. https://doi.org/10.7602/jmis.2020.23.1.43
- 15 March 2020
- Published by The Korean Society of Endo-Laparoscopic & Robotic Surgery in Journal of Minimally Invasive Surgery
- Vol. 23 (1) , 43-48
Open AccessUnmodifiable Clinicopathological Risk Factors of Shoulder Tip or Subcostal Pain after Laparoscopic Appendectomy
Bomi Kim, M.D., Jungbin Kim, M.D., Inseok Park, M.D., Hyunjin Cho, M.D., Geumhee Gwak, Ph.D., Keun Ho Yang, Ph.D., Byung-Noe Bae, Ph.D., Kihwan Kim, Ph.D.. Journal of Minimally Invasive Surgery 2020;23:43-8. https://doi.org/10.7602/jmis.2020.23.1.43
- Open Access
- 31 January 2020
- Published by Korean Society of Coloproctology in Annals of Coloproctology
Risk factors and management for left colonic perforation
To identify factors significantly associated with mortality of patients with left colonic perforation, and to compare the outcome of the Hartmann procedure (HP) and primary repair (PR) or primary anastomosis (PA) in left colonic perforation patients without factors associated with mortality. This retrospective study included patients who underwent surgery for left colonic perforation from January 2009 to February 2018. Preoperative factors related to postoperative mortality, including vital signs, laboratory findings, and intraoperative findings, were analyzed by type of operation. The chi-square, Fisher exact, and Mann-Whitney U tests were used to analyze the data. Ninety-one patients were included (36 men, 55 women), and 15 (16.5%) died postoperatively. Risk factors were age, leukopenia, thrombocytopenia, bleeding tendency, acute renal failure, hemodynamic instability, and existence of generalized peritonitis and feculent ascites. Advanced age, leukopenia, and acute renal failure were independent risk factors for mortality. Seventy-nine patients did not have leukopenia, and among them, 30 patients who underwent PR without diversion were excluded from the sub-analysis. HP was performed in 30 patients, and PR with diversion and PA with or without diversion were performed in 19. Compared to the other operative methods, HP had no benefit for reducing overall mortality (p=0.458) and morbidity. Leukopenia could be an objective prognostic factor for left colonic perforation. Although HP is the gold standard for septic left colonic perforation, it did not improve overall mortality of the patients without leukopenia. For such patients, PR or PA could be a good option for left colonic perforation.
- 31 January 2020
- Published by Korean Society of Coloproctology in Annals of Coloproctology
Open AccessRisk factors and management for left colonic perforation
To identify factors significantly associated with mortality of patients with left colonic perforation, and to compare the outcome of the Hartmann procedure (HP) and primary repair (PR) or primary anastomosis (PA) in left colonic perforation patients without factors associated with mortality. This retrospective study included patients who underwent surgery for left colonic perforation from January 2009 to February 2018. Preoperative factors related to postoperative mortality, including vital signs, laboratory findings, and intraoperative findings, were analyzed by type of operation. The chi-square, Fisher exact, and Mann-Whitney U tests were used to analyze the data. Ninety-one patients were included (36 men, 55 women), and 15 (16.5%) died postoperatively. Risk factors were age, leukopenia, thrombocytopenia, bleeding tendency, acute renal failure, hemodynamic instability, and existence of generalized peritonitis and feculent ascites. Advanced age, leukopenia, and acute renal failure were independent risk factors for mortality. Seventy-nine patients did not have leukopenia, and among them, 30 patients who underwent PR without diversion were excluded from the sub-analysis. HP was performed in 30 patients, and PR with diversion and PA with or without diversion were performed in 19. Compared to the other operative methods, HP had no benefit for reducing overall mortality (p=0.458) and morbidity. Leukopenia could be an objective prognostic factor for left colonic perforation. Although HP is the gold standard for septic left colonic perforation, it did not improve overall mortality of the patients without leukopenia. For such patients, PR or PA could be a good option for left colonic perforation.
- Open Access
- 28 February 2018
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 34 (1) , 4-10
Perioperative Serum Carcinoembryonic Antigen Ratio Is a Prognostic Indicator in Patients With Stage II Colorectal Cancer
Woo J, et al. Ann Coloproctol. 2018 Feb;34(1):4-10. https://doi.org/10.3393/ac.2018.34.1.4
- 28 February 2018
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 34 (1) , 4-10
Open AccessPerioperative Serum Carcinoembryonic Antigen Ratio Is a Prognostic Indicator in Patients With Stage II Colorectal Cancer
Woo J, et al. Ann Coloproctol. 2018 Feb;34(1):4-10. https://doi.org/10.3393/ac.2018.34.1.4
- Open Access
- 1 January 2017
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 30 (C) , 40-42
Rectal free perforation after stapled hemorrhoidopexy
INTRODUCTION: Stapled hemorrhoidopexy is widely performed for treatment of prolapsed hemorrhoids because of advantages, including shorter hospital stay and less discomfort, compared with conventional hemorrhoidectomy. However, it can have severe adverse effects, such as rectal bleeding, perforation, and sepsis. PRESENTATION OF CASE: We report the case of a healthy 28-year-old man who presented to the emergency department with sudden-onset diffuse abdominal pain and hematochezia. He had undergone stapled hemorrhoidopexy 5 days earlier and was discharged after an uneventful postoperative course. For the present condition, after immediate evaluation, we successfully performed emergency laparoscopic repair of the rectal perforation without any stoma. His postoperative course was uneventful, and he was discharged on postoperative day 16. DISCUSSION: This is a rare case of rectal perforation after stapled hemorrhoidopexy in which the perforation was treated successfully by laparoscopic repair. In most cases of rectal perforation following stapled hemorrhoidopexy, surgeons perform open laparotomy and create diverting stoma. However, our patient underwent totally laparoscopic lavage and primary closure without diverting stoma. Multiple investigators have reported that laparoscopic lavage for perforated diverticulitis may be an appropriate treatment option. Factors favoring this approach include early surgery, young age, sufficient irrigation, and meticulous primary closure. CONCLUSION: Stapled hemorrhoidopexy can have severe adverse effects, such as rectal bleeding, pelvic sepsis, and rectal perforation, which are potentially life-threatening. Laparoscopic lavage and primary repair without stoma can be performed successfully in select patients with rectal perforation following stapled hemorrhoidopexy. Highlights:
- 1 January 2017
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 30 (C) , 40-42
Open AccessRectal free perforation after stapled hemorrhoidopexy
INTRODUCTION: Stapled hemorrhoidopexy is widely performed for treatment of prolapsed hemorrhoids because of advantages, including shorter hospital stay and less discomfort, compared with conventional hemorrhoidectomy. However, it can have severe adverse effects, such as rectal bleeding, perforation, and sepsis. PRESENTATION OF CASE: We report the case of a healthy 28-year-old man who presented to the emergency department with sudden-onset diffuse abdominal pain and hematochezia. He had undergone stapled hemorrhoidopexy 5 days earlier and was discharged after an uneventful postoperative course. For the present condition, after immediate evaluation, we successfully performed emergency laparoscopic repair of the rectal perforation without any stoma. His postoperative course was uneventful, and he was discharged on postoperative day 16. DISCUSSION: This is a rare case of rectal perforation after stapled hemorrhoidopexy in which the perforation was treated successfully by laparoscopic repair. In most cases of rectal perforation following stapled hemorrhoidopexy, surgeons perform open laparotomy and create diverting stoma. However, our patient underwent totally laparoscopic lavage and primary closure without diverting stoma. Multiple investigators have reported that laparoscopic lavage for perforated diverticulitis may be an appropriate treatment option. Factors favoring this approach include early surgery, young age, sufficient irrigation, and meticulous primary closure. CONCLUSION: Stapled hemorrhoidopexy can have severe adverse effects, such as rectal bleeding, pelvic sepsis, and rectal perforation, which are potentially life-threatening. Laparoscopic lavage and primary repair without stoma can be performed successfully in select patients with rectal perforation following stapled hemorrhoidopexy. Highlights:
- Open Access
- 13 September 2016
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 14 (1) , 244
Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer
The luminal subtype of breast cancer is sensitive to anti-estrogen therapy and shows a better prognosis than that of human epidermal growth factor receptor2 (HER2)-enriched or triple-negative breast cancer. However, the luminal type of breast cancer is heterogeneous and can have aggressive clinical features. We investigated the clinical implications of single hormone receptor negativity in a luminal B HER2-negative group. We collected luminal B HER2-negative breast cancer data that were estrogen receptor (ER) and/or progesterone receptor (PR) positive, Ki 67 high (>14 %), and HER2 negative and divided them into the ER- and PR-positive group and the ER- or PR-negative group. We analyzed the clinical and pathological data and survival according to ER or PR loss. There were no statistical differences in TNM stage, breast and axillary operative methods, or number of tumors between the ER- and PR-positive group and ER- or PR-negative group. However, the ER- or PR-negative group was associated with older age (≥45 years), higher histological grade, lower Bcl-2 expression, and far higher Ki 67 (>50 %). Disease-free survival (DFS) and overall survival (OS) were shorter in the ER- or PR-negative group than that in the ER- and PR-positive group (p = 0.0038, p = 0.0071). ER- or PR-negative subgroup showed worse prognosis than ER- and PR-positive subgroup in the luminal B HER2-negative group. We could consider the negativity of ER or PR as prognostic marker in luminal B HER2-negative subtype of breast cancer.
- 13 September 2016
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 14 (1) , 244
Open AccessPrognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer
The luminal subtype of breast cancer is sensitive to anti-estrogen therapy and shows a better prognosis than that of human epidermal growth factor receptor2 (HER2)-enriched or triple-negative breast cancer. However, the luminal type of breast cancer is heterogeneous and can have aggressive clinical features. We investigated the clinical implications of single hormone receptor negativity in a luminal B HER2-negative group. We collected luminal B HER2-negative breast cancer data that were estrogen receptor (ER) and/or progesterone receptor (PR) positive, Ki 67 high (>14 %), and HER2 negative and divided them into the ER- and PR-positive group and the ER- or PR-negative group. We analyzed the clinical and pathological data and survival according to ER or PR loss. There were no statistical differences in TNM stage, breast and axillary operative methods, or number of tumors between the ER- and PR-positive group and ER- or PR-negative group. However, the ER- or PR-negative group was associated with older age (≥45 years), higher histological grade, lower Bcl-2 expression, and far higher Ki 67 (>50 %). Disease-free survival (DFS) and overall survival (OS) were shorter in the ER- or PR-negative group than that in the ER- and PR-positive group (p = 0.0038, p = 0.0071). ER- or PR-negative subgroup showed worse prognosis than ER- and PR-positive subgroup in the luminal B HER2-negative group. We could consider the negativity of ER or PR as prognostic marker in luminal B HER2-negative subtype of breast cancer.